ReviewFrontiers in immunology2026
From endocrine to immune: therapeutic potential of brown adipose tissue in remodelling the cardiovascular immune microenvironment.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brown adipose tissue (BAT) has transcended its classical role as an energy-dissipating thermogenic organ, emerging as a pivotal endocrine and immunoregulatory hub. This review systematically delineates the novel BAT endocrine mediator-cardiovascular immune microenvironment axis. We elucidate how BAT-derived secretomes, encompassing specific batokines, lipid mediators and extracellular vesicles(EVs), orchestrate profound cross-organ crosstalk to modulate systemic cardiovascular immunity. Pathophysiological stress, including obesity and ageing, precipitates BAT whitening and dysregulates local neuro-immune-metabolic reflex arcs, thereby exacerbating atherosclerosis(AS), hypertension and heart failure. Crucially, the phenotypic transformation of perivascular adipose tissue(PVAT) is intimately linked to localized vascular inflammation and macrophage polarization. Furthermore, we critically evaluate cutting-edge pharmacological interventions targeting key pathways, including FGF21 signaling, BAT-derived exosomes, and specific lipid mediators. These therapeutic modalities span conventional adrenergic activators, advanced nanotechnological delivery systems and cell-free epigenetic therapies. By circumventing the cardiovascular toxicities of systemic sympathetic overactivation, these targeted strategies precisely remodel the adipose microenvironment. Ultimately, harnessing the profound immunometabolic plasticity of BAT unveils a groundbreaking therapeutic paradigm for combatting advanced cardiometabolic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.